Anti-CD27 antibodies
US10556957B2 · kind B2 · utility
4Cited by
3References
59Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 25, 2017 |
| Grant date | Feb 11, 2020 |
| Priority date | — |
| Expiry date | Oct 23, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/73
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-CD27 antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.